Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0285 Transporter Info
Gene Name	SLC34A2
Transporter Name	Sodium-dependent phosphate transport protein 2B
Gene ID	10568
UniProt ID	O95436

Post-Translational Modification of This DT
Overview of SLC34A2 Modification Sites with Functional and Structural Information
Sequence	M A P W P E L G D A Q P N P D K Y L E G A A G Q Q P T A P D K S K E T N K T D N T E A P V T K I E L L P S Y S T A T L I D E P T E V D D P W N L P T L Q D S G I K W S E R D T K G K I L C F F Q G I G R L I L L L G F L Y F F V C S L D I L S S A F Q L V G G K M A G Q F F S N S S I M S N P L L G L V I G V L V T V L V Q S S S T S T S I V V S M V S S S L L T V R A A I P I I M G A N I G T S I T N T I V A L M Q V G D R S E F R R A F A G A T V H D F F N W L S V L V L L P V E V A T H Y L E I I T Q L I V E S F H F K N G E D A P D L L K V I T K P F T K L I V Q L D K K V I S Q I A M N D E K A K N K S L V K I W C K T F T N K T Q I N V T V P S T A N C T S P S L C W T D G I Q N W T M K N V T Y K E N I A K C Q H I F V N F H L P D L A V G T I L L I L S L L V L C G C L I M I V K I L G S V L K G Q V A T V I K K T I N T D F P F P F A W L T G Y L A I L V G A G M T F I V Q S S S V F T S A L T P L I G I G V I T I E R A Y P L T L G S N I G T T T T A I L A A L A S P G N A L R S S L Q I A L C H F F F N I S G I L L W Y P I P F T R L P I R M A K G L G N I S A K Y R W F A V F Y L I I F F F L I P L T V F G L S L A G W R V L V G V G V P V V F I I I L V L C L R L L Q S R C P R V L P K K L Q N W N F L P L W M R S L K P W D A V V S K F T G C F Q M R C C C C C R V C C R A C C L L C D C P K C C R C S K C C E D L E E A Q E G Q D V P V K A P E T F D N I T I S R E A Q G E V P A S D S K T E C T A L
PTM type	X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation
Asparagine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC34A2			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	295
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC34A2 Asparagine 295 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC34A2			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	308
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC34A2 Asparagine 308 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC34A2			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	313
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC34A2 Asparagine 313 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC34A2			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	321
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC34A2 Asparagine 321 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC34A2			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	340
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC34A2 Asparagine 340 has the potential to affect its expression or activity.
Phosphorylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC34A2			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	687
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC34A2 Cystine 687 has the potential to affect its expression or activity.
Serine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC34A2			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	53
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC34A2 Serine 53 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC34A2			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	55
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC34A2 Serine 55 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC34A2			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	671
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC34A2 Serine 671 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC34A2			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	681
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC34A2 Serine 681 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC34A2			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	683
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC34A2 Serine 683 has the potential to affect its expression or activity.
Threonine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC34A2			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	56
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC34A2 Threonine 56 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC34A2			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	58
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC34A2 Threonine 58 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC34A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	669
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC34A2 Threonine 669 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC34A2			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	685
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC34A2 Threonine 685 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC34A2			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	688
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC34A2 Threonine 688 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC34A2			[4] , [8]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	17
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC34A2 Tyrosine 17 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC34A2			[4] , [8]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	54
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC34A2 Tyrosine 54 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: NPT2B_HUMAN)
2	Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Mol Cell. 2020 Dec 17;80(6):1104-1122.e9.
3	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
4	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
5	Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics. Proteomics. 2015 Jan;15(2-3):340-55.
6	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
7	Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer. Cell Rep. 2017 Mar 28;18(13):3242-3256.
8	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence